显著上调的血清血红素4A作为肌痛性骨髓灰质炎的新型活性标志物
Akiyuki Uzawa1, Manato Yasuda1, Hiroyuki Akamine1
1Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Scandinavian journal of immunology
|April 12, 2024
概括
血红素4A (Sema4A) 水平升高表明T细胞在肌痛性严重性 (MG) 中的激活. 这表明Sema4A可能作为MG疾病活动的生物标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 生物化学 生物化学
背景情况:
- 骨髓灰质炎 (MG) 是一种影响神经肌肉结合的自身免疫性疾病.
- 赛马福林4A (Sema4A) 在炎症条件下与T细胞激活有关.
研究的目的:
- 调查Sema4A在肌痛性骨髓灰质炎的发病过程中的作用.
- 为了确定MG患者的血清Sema4A水平是否升高.
主要方法:
- 血清Sema4A度测量了30名先前未接受治疗的乙胆受体 (AChR) 抗体阳性MG患者,7名MuSK抗体阳性MG患者和21名健康对照.
- 分析了Sema4A水平,ACHR抗体标位和疾病严重程度之间的相关性.
主要成果:
- 与对照人群相比,血清Sema4A水平在AMR阳性和MuSK阳性MG患者中显著更高 (p≤0.0001).
- 在ACHR阳性MG中,Sema4A水平与ACHR抗体度 (ρ=0.39,p=0.03) 和疾病分类 (ρ=0.38,p=0.04) 相相关.
结论:
- 在MG患者中血清Sema4A升高表明T细胞激活.
- 塞马4A可能代表一个潜在的生物标志物,用于评估严重骨髓灰质炎的疾病活性.
更多相关视频
相关概念视频
01:15Myasthenia Gravis: Diagnostic Tests
810
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
810
01:20Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K